Secondary Endolymphatic Hydrops and Vestibular Schwannomas on 3 Tesla MRI
NCT03593577 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 185
Last updated 2018-07-20
Summary
Endolymphatic hydrops is well known of the lay public in its primary form that is Ménière disease. Nowadays, the best w ay to approach it in vivo, is to use magnetic resonance imaging (MRI).
However, endolymphatic hydrops don't limit itself to its primary form but cover a whole range of pathologies.
The hypothesis is that patients with vestibular schwannomas are more likely to develop secondary saccular hydrops.
The aim is to compare high-resolution T2-weighted images of the saccule in patients followed up for vestibular schwannomas with healthy volunteers and histological sections from cadavers in order to identify its changes.
The secondary purpose of The protocol is to determine if vestibular and audiometric abnormalities could be related to this secondary hydrops more specifically than to the tumor size and localisation.
Conditions
- Vestibular Schwannoma
Sponsors & Collaborators
-
University Hospital, Strasbourg, France
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-06-01
- Primary Completion
- 2019-06-30
- Completion
- 2019-06-30
Countries
- France
Study Locations
More Related Trials
-
Usefulness of Non EPI-DWI-MRI / CT 3D Static Co-registration Prior to Surgery of Cholesteatomas
NCT02903550 ·Status: UNKNOWN
-
Evolution of Vestibular Function After Treatment of a Vestibular Schwannoma by Gamma-knife Radio-surgery
NCT06112509 ·Status: RECRUITING ·Phase: NA
-
Study of Brain and Spinal Cord Tumor Growth and Cyst Development in Patients With Von Hippel Lindau Disease
NCT00005902 ·Status: ACTIVE_NOT_RECRUITING
-
Clinical Study of Structural and Functional Evaluation of the Visual Pathway
NCT03591315 ·Status: UNKNOWN
-
Assessment of Volumetric Growth Rates of Spinal Intradural Extramedullary Schwannoma
NCT01951365 ·Status: COMPLETED
-
Evolution of Balance and Vestibular Function in Patients Treated With Gammaknife Radiosurgery for Vestibular Schwannoma
NCT04859335 ·Status: RECRUITING ·Phase: NA
-
MR Fingerprinting for Vestibular Schwannomas
NCT04851925 ·Status: RECRUITING
-
Using Positron Emission Tomography to Predict Intracranial Tumor Growth in Neurofibromatosis Type II Patients
NCT01222728 ·Status: COMPLETED
-
RGD PET/MRI in Sporadic Vestibular Schwannoma
NCT03393689 ·Status: UNKNOWN ·Phase: PHASE2
-
Vestibular Schwannoma Organoids
NCT05786144 ·Status: COMPLETED
-
Radiosurgery Induced Ototoxicity in Patients Treated for a Vestibular Schwannoma
NCT05641441 ·Status: RECRUITING
-
Cyberknife Radiosurgery for Patients With Neurinomas
NCT02055859 ·Status: UNKNOWN ·Phase: NA
-
Vestibular Schwannoma - Radiosurgery or Expectation: V-REX.
NCT02249572 ·Status: COMPLETED ·Phase: NA
-
Stereotactic Radiation in Vestibular Schwannoma
NCT01449604 ·Status: UNKNOWN ·Phase: PHASE3
-
Detection of Cholesteatoma Using Diffusion Magnetic Resonance Imaging
NCT03305796 ·Status: UNKNOWN
-
Acoustic Neuroma: Assessing the Quality of Life by the Scale PANQOL of Patients Operated or Supervised
NCT04004377 ·Status: UNKNOWN
-
Prediction of Sphenoid Septation in MRI Compared With CT and Intraoperative Findings During Endoscopic Pituitary Adenoma Surgery
NCT03624114 ·Status: COMPLETED
-
WES of NF2-associated in Comparison to Sporadic Vestibular Schwannomas - Correlation With Clinical Data
NCT03210285 ·Status: COMPLETED
-
Reliability of Functional Outcome Measures in Neurofibromatosis 2
NCT03617276 ·Status: COMPLETED
-
Clinical, Radiological, Histologic and Molecular Features of a Cohort of Melanocytic Tumors of the Central Nervous System
NCT05984108 ·Status: UNKNOWN
-
Level of Middle Cranial Fossa Dura in Patients With Cholesteatoma
NCT04551612 ·Status: UNKNOWN
-
MEningioma Detection Using Non Contrast MRI TecHniquEs
NCT04113408 ·Status: TERMINATED
-
Interest of Using Deep Learning Algorithm for Otosclerosis Detection on Temporal Bone High Resolution CT
NCT05987215 ·Status: UNKNOWN
-
68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.
NCT04081701 ·Status: RECRUITING ·Phase: PHASE4
-
89Zr-Bevacizumab PET/CT Imaging in NF2 Patients
NCT05685836 ·Status: RECRUITING